Nuedexta

pulls plug pulling plug
Pharma

Otsuka gives up on Alzheimer's drug after 2nd failed trial

Otsuka is packing up an Alzheimer’s disease med after a phase 3 study failed to move the needle on measures of agitation associated with dementia.
California

Otsuka's Avanir unit plots 140 layoffs after Nuedexta settlement

Jan 10, 2020 11:35am
contract

Otsuka expects to pay $120M to wrap the feds' Nuedexta probe

Feb 14, 2019 11:54am
fda

Medicare alert draws attention to use of Nuedexta

Jun 4, 2018 11:18am
Pills

Did Avanir overmarket its brain drug to the elderly?

Oct 13, 2017 10:25am
PBA Facts TV Commercial

Overwrought marketing? Ads, not research, create some pharma best-sellers

May 17, 2017 9:48am